Is Zinc Pyrithione safe in cosmetics?
Zinc Pyrithione has a safety rating of "MODERATE" in our database. EU status: prohibited. US status: permitted. 10 toxicological study endpoint(s) are available in our database.
Also known as: Zinc, bis[1-(hydroxy-kappaO)-2(1H)-pyridinethionato-.kappa.S2]-, (T-4)-, Zinc, bis(1-hydroxy-2(1H)-pyridinethionato)-, Zinc, bis(1-hydroxy-2(1H)-pyridinethionato-O,S)-, (T-4)-, Zinc, bis(1-(hydroxy-kappaO)-2(1H)-pyridinethionato-kappaS2)-, (T-4)-, Zinc, bis[1-(hydroxy-.kappa.O)-2(1H)-pyridinethionato-.kappa.S2]-, (T-4)- (+14 more)
INCI: ZINC PYRITHIONE
Zinc Pyrithione (CAS 13463-41-7) is a cosmetic active ingredient functioning as Anti-dandruff active; preservative (historical EU). NOAEL 0.167 mg/kg bw/day (PDF-verified against ToxValDB ECHA IUCLID); EU Regulation 1223/2009 status: prohibited, max 0%. Industrial safety data is also available in the chemical safety database. Same-CAS public records also appear in industrial chemical safety and pharmaceutical data.
View industrial chemical safety profile for CAS 13463-41-7 →
Zinc Pyrithione is prohibited in EU cosmetics at max 0% but has active industrial GHS classifications (H301, H302, H318, H330, H331, H332, H372, H400).
Source: Cosmetics: ingredients.eu status/eu max; Chemicals: ghs classifications.signal word/hazard statement code
For full compliance data across multiple jurisdictions, use the Substance Compliance tool.
Margin of Safety, dermal absorption, and sensitization profile summaries for Zinc Pyrithione.
Calculate MoS for your specific formulation with the MoS Calculator.
10 study endpoints found for Zinc Pyrithione. NOAEL (No Observed Adverse Effect Level) values are used to calculate the Margin of Safety per SCCS methodology.
| Endpoint | Value | Route | Species | Study Type | Source |
|---|---|---|---|---|---|
| NOAEL | 0.20000000298 mg/kg bw/day | oral | rat | Subchronic | COSMOS DB |
| NOAEL | =0.6 mg/kg/d | oral | rat | NOAEL study | SCCNFP Opinion |
| NOAEL | =0.6 mg/kg/d | oral | rat | NOAEL study | SCCNFP Opinion |
| NOAEL | =0.6 mg/kg/d | oral | rat | NOAEL study | SCCNFP Opinion |
| NOAEL | =0.6 mg/kg/d | oral | rat | NOAEL study | SCCNFP Opinion |
| NOAEL | =400 mg/kg/day | oral | rat | reproductive toxicity | SCCNFP Opinion |
| NOAEL | =400 mg/kg/day | oral | rat | reproductive toxicity | SCCNFP Opinion |
| NOAEL | =400 mg/kg/day | oral | rat | reproductive toxicity | SCCNFP Opinion |
| NOAEL | =400 mg/kg/day | oral | rat | reproductive toxicity | SCCNFP Opinion |
| NOAEL | =2 mg/kg/d | oral | - | NOAEL study | SCCS Opinion |
Pre-calculated NOAEL → SED → MoS audit trail for Zinc Pyrithione across SCCS product categories, with measured dermal absorption where available.
NOAEL/LOAEL values cited in official SCCS opinions for Zinc Pyrithione.
| NOAEL | LOAEL | Route | Species | Study | DA% (SCCS) | Opinion |
|---|---|---|---|---|---|---|
| 2.5 mg/kg/day | 5 mg/kg/day | Oral | Rat | Subchronic (90-day) (90 days (gavage)) | 100 | SCCS/1614/19 (2020) |
| 1 mg/kg/day | 5 mg/kg/day | Oral | Rat | Subchronic (90-day) (90 days) | 100 | SCCS/1512/13 (2013) |
Contact sensitization data for Zinc Pyrithione based on clinical patch test studies and IFRA standards.
Source: ESSCA; IVDK; NACDG
10 toxicity values from EPA ToxValDB (aggregated from CCTE, HPV, ToxRefDB, IRIS, and other regulatory dossiers).
| Endpoint | Value | Species | Route | Duration | Source |
|---|---|---|---|---|---|
| LC50 | =140 mg/m3 | Rat | inhalation | - | ECHA |
| LC50 | =1340 mg/m3 | Rat | inhalation | - | ECHA |
| LC50 | =840 mg/m3 | Rat | inhalation | - | ECHA |
| LC50 | =1030 mg/m3 | Rat | inhalation | - | ECHA |
| LD50 | >2000 mg/kg | Rat | dermal | acute | ECHA |
| LD50 | =774 mg/kg | Rat | oral | - | ECHA |
| LD50 | =302 mg/kg | Rat | oral | - | ECHA |
| LD50 | =221 mg/kg | Rat | oral | - | ECHA |
| LD50 | =269 mg/kg | Rat | oral | - | ECHA |
| LOAEL | =1.95 mg/kg-day | Rat | oral | - | ECHA |
Legally binding harmonized classification per Regulation (EC) No 1272/2008 (CLP) Annex VI.
Inserted via ATP: ATP15
Adverse Outcome Pathway data across 5 assays (DPRA, KeratinoSens, hCLAT, LLNA, NESIL) aggregated from public sources.
Source: HPPT: [228] Marzulli FN and Maibach HI (1973): https://library.scconline.org/v024n07/
2 human repeat insult patch tests aggregated from dermatological literature.
| Test Type | N | Sensitized | Dose µg/cm² | NESIL µg/cm² | Potency |
|---|---|---|---|---|---|
| HRIPT | - | 0 | 852.5 | - | - |
| HRIPT | - | 0 | 2092.5 | - | - |
Cross-referenced EDC classifications, mechanism data, and dose-response evidence from EDLists, SIN List, and cosmetic-specific detail sources.
inhibitor (steroidogenesis); modulator (TR)
| Endpoint | Target | Value | Direction |
|---|---|---|---|
| Testosterone and E2 secretion; CYP19 (aromatase) disruption | steroidogenesis; TR (indirect) | EC50/IC50: LOEC ~0.1 uM (H295R); IC50 for aromatase ~0.1-1 uM; LOEC: 0.1 uM; NOEC: 0.01 uM mixed | inhibitor (steroidogenesis) |
| Estrogenic activity (MCF-7 proliferation; uterine weight) | ERα (indirect, weak) | EC50/IC50: No significant cell proliferation at non-cytotoxic concentrations (≤10⁻⁶ M); EPA EDSP ER bioactivity score 0.237; LOEC: 10⁻⁶ M (borderline cytotoxic); NOEC: N/A mixed | weak estrogenic (low potency) |
| AR agonism/antagonism | AR | EC50/IC50: No significant AR activity reported in standard assays at sub-cytotoxic concentrations; LOEC: not established; NOEC: not established mixed | weak AR activity (data limited) |
| Thyroid peroxidase enzyme activity inhibition | Thyroid peroxidase (TPO) | EC50/IC50: IC50 ~15–25 µM (rat thyroid microsomes; pyrithione moiety chelates heme iron); LOEC: ~5 µM; NOEC: not determined mixed | inhibitor |
| AR agonism/antagonism | AR | EC50/IC50: No significant AR activity at non-cytotoxic doses (<0.5 µM); LOEC: not established; NOEC: N/A mixed | not active at sub-cytotoxic concentrations |
European Chemicals Agency REACH dossier and Substances of Very High Concern listing.
European Commission CosIng database Annex references per Regulation (EC) No 1223/2009.
Additional regulatory detail beyond the 7-jurisdiction summary: Saudi SFDA, Korea MFDS, ASEAN ACD, Japan/Korea, Brazil/India, and cross-jurisdictional restriction entries.
| Jurisdiction | Status | Max % | Product Type |
|---|---|---|---|
| JP | restricted | Wash-away: 0.10% | Leave-on: 0.010% | Mucosa: 0.010% | Wash-away: 0.10% | Leave-on: 0.010% | Mucosa: 0.010% |
| CN | restricted | 1 | (a) Anti-dandruff rinse-off hair products (b) Other rinse-off products |
| CN | permitted_preservative | 0.5 | (a) Anti-dandruff rinse-off (b) Other rinse-off |
| IN | permitted_preservative | 1.0 | hair rinse-off products only |
| IN | permitted_preservative | 0.5 | other cosmetic products (non-hair, rinse-off only) |
| GCC | restricted | 2.0 | Rinse-off hair products |
| BR | banned | - | In Brazil: permitted as rinse-off anti-dandruff 1% and non-oxidative hair dye solvent (RDC 806/2023); unlike EU where fully banned |
| BR | restricted | 1 (rinse-off) / 0.25 (leave-on) | a) Rinse-off anti-dandruff hair products: 1%; b) Leave-on anti-dandruff products: 0.25%; also: non-oxidative hair dye solvent (rinse-off): per RDC 806/2023 |
Reported concentration ranges per product category from SCCS/CIR/industry sources.
| Product Category | Typical Range | Max Reported | Source |
|---|---|---|---|
| Antidandruff Shampoo | 0.3–2 | 2 | FDA |
9 property records from structured ingredient metadata.
Expert safety assessment and concern-level summary for Zinc Pyrithione.
Public NOAEL study rows linked to Zinc Pyrithione by CAS number or substance name.
Units vary across source rows: mg/kg bw/day, mg/kg/d, mg/kg bw/d
Same-CAS public records found in pharmaceutical data.
Same-CAS rows from the pharmaceutical spoke database.
Zinc Pyrithione has a safety rating of "MODERATE" in our database. EU status: prohibited. US status: permitted. 10 toxicological study endpoint(s) are available in our database.
Zinc Pyrithione EU regulatory status: prohibited. Maximum allowed concentration: 0%. This is based on EU Regulation 1223/2009 and its amendments.
Zinc Pyrithione functions as: Anti-dandruff active; preservative (historical EU). It is classified as a Active Ingredient in our database. CAS number: 13463-41-7.
The NOAEL (No Observed Adverse Effect Level) for Zinc Pyrithione is 0.20000000298 mg/kg bw/day based on a Subchronic study via oral route in rat. A total of 10 study endpoints are available. Source: COSMOS DB.
Zinc Pyrithione also appears in industrial chemical safety and pharmaceutical data. The cross-vertical cards on this page render same-CAS public rows from the matched databases.
Zinc Pyrithione is prohibited in EU cosmetics at max 0% but has active industrial GHS classifications (H301, H302, H318, H330, H331, H332, H372, H400).
Check Zinc Pyrithione compliance across multiple jurisdictions:
Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.
Try Piro Free →Paste any INCI list into the Decoder for instant safety analysis, or calculate the Margin of Safety for Zinc Pyrithione in your formulation.